Kolexia
Michallet Mauricette Médecine générale
Michallet Mauricette
Médecine générale
Centre Léon-Bérard
Lyon, France
605 Activités
784 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie myéloïde Leucémie aigüe myéloïde Maladie du greffon contre l'hôte Tumeurs hématologiques Leucémie myéloïde chronique BCR-ABL positive Myélome multiple Syndromes myélodysplasiques Maladie aigüe

Collaborateurs

Voir plus
Mohty Mohamad
Mohty Mohamad
Hôpital Saint-Antoine, Paris, France
Yakoub-Agha Ibrahim
Yakoub-Agha Ibrahim
Centre Hospitalier de Lille, Lille, France
Socie Gerard
Socie Gerard
Hôpital Saint-Louis, Paris, France
Nicolini Franck
Nicolini Franck
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
BMS
5 collaboration(s)
Dernière en 2023
Astellas
3 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2021
Sanofi
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
ORHEO: Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Essai Clinique (Pfizer)   26 février 2024
PASCA -MM: PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
Essai Clinique (Centre Léon-Bérard)   20 février 2024
Second line extracorporeal photopheresis for cortico-resistant acute and chronic GVHD after allogeneic hematopoietic cell transplantation for hematological malignancies: Long-term results from a real-life study.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis   16 février 2024
Mauricette Michallet Faire face à la maladie grave
Youtube @ Editions Eres   01 janvier 2024
Pharmacokinetic Consideration of Venetoclax in Acute Myeloid Leukemia Patients: A Potential Candidate for TDM? A Short Communication.
Therapeutic drug monitoring   08 novembre 2023
Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory Settings: A Multicentric Study from French Auraml Group
65th ASH Annual Meeting Abstracts   02 novembre 2023
Long-Term Outcome of Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation (ASCT) - Impact of Therapeutic Strategy Following ASCT
65th ASH Annual Meeting Abstracts   02 novembre 2023
MM-074 How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
POSTER: MM-074 How can Different Therapeutic Strategies and Financial Resources Impact Outcomes After Autologous Stem Cell Transplantation in Myeloma? Study in France and Algeria
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
PASCA: Study of Complications Related to Treatments in Adults Aged 18 to 65 Years Old Responding to a First Treatment in Oncology or Onco-hematology and Participating in the PASCA (PArcours de Santé au Cours du CAncer) Post-treatment Program.
Essai Clinique (Centre Léon-Bérard)   29 août 2023